A complex history

Sorting Out Cabilly

Genentech Inc.'s Cabilly II patent, which claims methods for producing monoclonal antibodies, has a complex history that involves Celltech Group plc's Boss patent, which covered the same space, and a controversial deal between the two companies. ...